JUXEVA Trademark

Trademark Overview


On Thursday, June 11, 2020, a trademark application was filed for JUXEVA with the United States Patent and Trademark Office. The USPTO has given the JUXEVA trademark a serial number of 88960334. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 5, 2021. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The JUXEVA trademark is filed in the Pharmaceutical Products category with the following description:

Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of t...
juxeva

General Information


Serial Number88960334
Word MarkJUXEVA
Filing DateThursday, June 11, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements


Goods and ServicesContraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of the urogenital organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; all the foregoing pharmaceuticals for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Tuesday, July 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2020ASSIGNED TO EXAMINER
Wednesday, July 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 15, 2020NEW APPLICATION ENTERED IN TRAM